Drugs / Diptheria and tetanus toxoids and accelular pertussis vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00488826 | Oct 2005 → May 2007 | pneumococcal infection | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diptheria and tetanus toxoids and accelular pertussis vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00488826 ↗ |
| Known as | DTaP | “Diptheria and tetanus toxoids and accelular pertussis vaccine (DTaP)” NCT00488826 ↗ |
| Modality | Vaccine | “Diptheria and tetanus toxoids and accelular pertussis vaccine (DTaP)” NCT00488826 ↗ |